SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-23-010726
Filing Date
2023-02-13
Accepted
2023-02-13 16:02:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13G ea173368-13ga1zwyer_nlspharm.htm SC 13G/A 46969
  Complete submission text file 0001213900-23-010726.txt   48190
Mailing Address THE CIRCLE 6 8058 ZURICH V8 CH-6370
Business Address THE CIRCLE 6 8058 ZURICH V8 CH-6370 41-41-618-80-00
NLS Pharmaceutics Ltd. (Subject) CIK: 0001783036 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92065 | Film No.: 23618187
SIC: 2834 Pharmaceutical Preparations

Mailing Address ALTER POSTPLATZ 2 STANS V8 CH-6370
Business Address
Zwyer Alexander (Filed by) CIK: 0001861769 (see all company filings)

Type: SC 13G/A